Results 231 to 240 of about 36,553 (257)

Vaccination of sheep against Fasciola hepatica with homologous fatty acid binding proteins

Veterinary Parasitology, 2001
The current study was designed to test the immunoprophylactic properties of native (nFh12) and recombinant (rFh15) antigens from Fasciola hepatica in sheep subsequently infected with the fluke. Thirty lambs were divided into six groups according to various patterns of immunisation and times of infection and necropsy.
V, Ramajo, A, Oleaga, P, Casanueva, G V, Hillyer, A, Muro   +4 more
openaire   +2 more sources

Safety and immunogenicity of a third-dose homologous BBIBP-CorV boosting vaccination: interim results from a prospective open-label study

Emerging Microbes and Infections, 2022
Chao Qiu, Qiran Zhang, Wenhong Zhang
exaly  

Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study

Lancet, The, 2022
Merryn Voysey, Aj Pollard, TERESA Lambe   +2 more
exaly  

Human papillomavirus vaccination 2020 guideline update: American Cancer Society guideline adaptation

Ca-A Cancer Journal for Clinicians, 2020
Robert Smith
exaly  

Heterologous ChAdOx1/BNT162b2 vaccination induces stronger immune response than homologous ChAdOx1 vaccination: The pragmatic, multi-center, three-arm, partially randomized HEVACC trial

EBioMedicine, 2022
Sebastian Schoenherr, Alessandro Sette, Wegene Borena   +2 more
exaly  

[Superiority of homologous rabies vaccines].

Bulletin - Office international des epizooties, 1972
K N, Boutchnev, E A, Aissen, I L, Kvassov   +2 more
openaire   +1 more source

Interdependencies of cellular and humoral immune responses in heterologous and homologous SARS‐CoV‐2 vaccination

Allergy: European Journal of Allergy and Clinical Immunology, 2022
Andreas Erich Zautner, Moritz Schnelle, Lennart Münsterkötter   +2 more
exaly  

Human papillomavirus vaccination guideline update: American Cancer Society guideline endorsement

Ca-A Cancer Journal for Clinicians, 2016
Lacey Loomer, Robert Smith
exaly  

[Apropos of the sensitivity of B.C.G. vaccine to homologous tuberculoprotein].

La Revue lyonnaise de medecine, 1968
V, Golli, D, Stavri
openaire   +1 more source

Factors influencing the protective efficacy of a BCG homologous prime-boost vaccination regime against tuberculosis

Vaccine, 2006
C G Mackintosh, J F T Griffin, J F T Griffin   +2 more
exaly